HLB Science (XKRX:343090) Days Sales Outstanding : 0.00 (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science Days Sales Outstanding?

HLB Science's average Accounts Receivable for the three months ended in . 20 was ₩0.00 Mil. HLB Science's Revenue for the three months ended in . 20 was ₩0.00 Mil.

The historical rank and industry rank for HLB Science's Days Sales Outstanding or its related term are showing as below:

XKRX:343090's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 73.01
* Ranked among companies with meaningful Days Sales Outstanding only.

HLB Science's Days Sales Outstanding stayed the same from . 20 (0.00) to . 20 (0.00).

HLB Science Days Sales Outstanding Historical Data

The historical data trend for HLB Science's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Days Sales Outstanding Chart

HLB Science Annual Data

Trend

Dec22

Dec23

Days Sales Outstanding

HLB Science Quarterly Data

Days Sales Outstanding

Competitive Comparison of HLB Science's Days Sales Outstanding

For the Biotechnology subindustry, HLB Science's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Science's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HLB Science's Days Sales Outstanding falls into.

HLB Science Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HLB Science's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

HLB Science's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding (Q: . 20 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )	/	Revenue (A: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365 / 4
=	0					/		*	365 / 4
=	N/A

HLB Science (XKRX:343090) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

HLB Science Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HLB Science's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines